- Home
- Publications
- Publication Search
- Publication Details
Title
Pegvisomant in acromegaly: an update
Authors
Keywords
Acromegaly, Pegvisomant, Review, SRL resistance, Metabolic effects, IGF-I
Journal
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 40, Issue 6, Pages 577-589
Publisher
Springer Nature
Online
2017-02-08
DOI
10.1007/s40618-017-0614-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment with high doses of pegvisomant in 56 patients with acromegaly: experience from ACROSTUDY
- (2016) Aart Jan van der Lely et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Effect of the Exon-3-Deleted Growth Hormone Receptor on Pegvisomant-Treated Acromegaly: A Systematic Review and Meta-Analysis
- (2016) Sanne E. Franck et al. NEUROENDOCRINOLOGY
- Current and Emerging Aspects of Diabetes Mellitus in Acromegaly
- (2016) Stefano Frara et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Treatment of acromegaly in the era of personalized and predictive medicine
- (2015) Manuel Puig Domingo CLINICAL ENDOCRINOLOGY
- X-linked acrogigantism syndrome: clinical profile and therapeutic responses
- (2015) A. Beckers et al. ENDOCRINE-RELATED CANCER
- Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study
- (2015) Emmanuelle Kuhn et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3
- (2015) S E Franck et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Bone Turnover, Bone Mineral Density, and Fracture Risk in Acromegaly: A Meta-Analysis
- (2015) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pegvisomant Treatment in Acromegaly
- (2015) Sebastian J.C.M.M. Neggers et al. NEUROENDOCRINOLOGY
- Bone and Joint Disorders in Acromegaly
- (2015) Kim M.J.A. Claessen et al. NEUROENDOCRINOLOGY
- Prediction of therapy response in acromegalic patients under pegvisomant therapy within the German ACROSTUDY cohort
- (2015) Caroline Sievers et al. Pituitary
- Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly
- (2015) Raquel S. Jallad et al. Pituitary
- Does pegvisomant treatment expertise improve control of resistant acromegaly? The Italian ACROSTUDY experience
- (2015) S. Cannavo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Insulin and GH–IGF-I axis: endocrine pacer or endocrine disruptor?
- (2014) Andrea Giustina et al. ACTA DIABETOLOGICA
- Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre Spanish study
- (2014) Gemma Sesmilo et al. CLINICAL ENDOCRINOLOGY
- Therapy of acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to normalise IGF1 levels
- (2014) Michael Droste et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors
- (2014) Andrea Giustina et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly
- (2014) S. J. C. M. M. Neggers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prospective Study of Surgical Treatment of Acromegaly: Effects on Ghrelin, Weight, Adiposity, and Markers of CV Risk
- (2014) Carlos Reyes-Vidal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The management of the patient with acromegaly and headache: A still open clinical challenge
- (2014) A. Giustina et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults
- (2014) A. Giustina et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy
- (2014) E. Ghigo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group
- (2014) E. De Menis et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Expert consensus document: A consensus on the medical treatment of acromegaly
- (2014) Andrea Giustina et al. Nature Reviews Endocrinology
- Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study
- (2014) Michael Sheppard et al. Pituitary
- Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline
- (2014) A. Giustina et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status
- (2014) Rosario Pivonello et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- Acromegaly and pregnancy: a prospective study
- (2013) Monike Dias et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Octreotide for acromegaly treatment: a reappraisal
- (2013) Andrea Giustina et al. EXPERT OPINION ON PHARMACOTHERAPY
- Acromégalie et grossesse : six nouvelles observations
- (2013) M.-L. Persechini et al. JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION
- Vertebral Fractures in Patients With Acromegaly: A 3-Year Prospective Study
- (2013) G. Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes
- (2013) Antonio Bianchi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Biochemical and quality of life responses to octreotide-LAR in acromegaly
- (2013) Ruth Mangupli et al. Pituitary
- Impact of treatment satisfaction on quality of life of patients with acromegaly
- (2013) Hasan Kepicoglu et al. Pituitary
- The role of combination medical therapy in acromegaly
- (2013) Maria Fleseriu Current Opinion in Endocrinology Diabetes and Obesity
- AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression
- (2012) Leandro Kasuki et al. ENDOCRINE-RELATED CANCER
- Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY
- (2012) A. J. van der Lely et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A consensus on the diagnosis and treatment of acromegaly complications
- (2012) S. Melmed et al. Pituitary
- Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
- (2012) Andrea Giustina et al. PLoS One
- Elevated incidence of sleep apnoea in acromegaly—correlation to disease activity
- (2012) J. Roemmler et al. Sleep and Breathing
- Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor Assays
- (2011) D. R. Clemmons et al. CLINICAL CHEMISTRY
- Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature
- (2011) Sonia Cheng et al. CLINICAL ENDOCRINOLOGY
- Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy
- (2011) Gherardo Mazziotti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Combination treatment with somatostatin analogues and pegvisomant in acromegaly
- (2011) S.J.C.M.M. Neggers et al. GROWTH HORMONE & IGF RESEARCH
- Cotreatment with Pegvisomant and a Somatostatin Analog (SA) in SA-Responsive Acromegalic Patients
- (2011) Michael Madsen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Growth Hormone Receptor Variants and Response to Pegvisomant in Monotherapy or in Combination with Somatostatin Analogs in Acromegalic Patients: A Multicenter Study
- (2011) M. Filopanti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pregnancy and acromegaly: a review
- (2011) Vicky Cheng et al. Pituitary
- Inhibition of Growth Hormone Receptor Activation by Pegvisomant may Increase Bone Density in Acromegaly
- (2010) C. Jimenez et al. HORMONE AND METABOLIC RESEARCH
- Female Gonadal Function before and after Treatment of Acromegaly
- (2010) Michaël Grynberg et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly and Pregnancy: A Retrospective Multicenter Study of 59 Pregnancies in 46 Women
- (2010) Philippe Caron et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Consensus on Criteria for Cure of Acromegaly
- (2010) A. Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatotroph Tumor Progression during Pegvisomant Therapy: A Clinical and Molecular Study
- (2010) M. Marazuela et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review
- (2010) Maria Fleseriu Pituitary
- A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly
- (2009) Peter J. Trainer et al. CLINICAL ENDOCRINOLOGY
- Effects of octreotide exposure during pregnancy in acromegaly
- (2009) Pietro Maffei et al. CLINICAL ENDOCRINOLOGY
- Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed
- (2009) Tirissa J. Reid et al. CLINICAL ENDOCRINOLOGY
- Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy
- (2009) Mónica Marazuela et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Successful use of weekly pegvisomant administration in patients with acromegaly
- (2009) C E Higham et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial
- (2009) Andrea Giustina et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- ACROSTUDY: the first 5 years
- (2009) Peter J Trainer EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly
- (2009) C Berg et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The German ACROSTUDY: past and present
- (2009) M Buchfelder et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Influence of Growth Hormone Receptor d3 and Full-Length Isoforms on Biochemical Treatment Outcomes in Acromegaly
- (2009) Antonio Bianchi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pegvisomant Improves Insulin Sensitivity and Reduces Overnight Free Fatty Acid Concentrations in Patients with Acromegaly
- (2009) C. E. Higham et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
- (2009) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Guidelines for Acromegaly Management: An Update
- (2009) S. Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly
- (2009) Ignacio Bernabeu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-term experience of pegvisomant therapy as a treatment for acromegaly
- (2008) C. E. Higham et al. CLINICAL ENDOCRINOLOGY
- Subcutaneous lipoatrophy induced by long-term pegvisomant administration
- (2008) Cannavo Salvatore et al. CLINICAL ENDOCRINOLOGY
- Pegvisomant increases intra-abdominal fat in patients with acromegaly: a pilot study.
- (2008) U Plöckinger et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease
- (2008) Maria Vittoria Davi' et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance
- (2008) Maria P Matta et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Lipodystrophy in Patients with Acromegaly Receiving Pegvisomant
- (2008) Vivien S. Bonert et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prevalence of Vertebral Fractures in Men with Acromegaly
- (2008) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly
- (2008) Antonio Bianchi et al. Pituitary
- Alterations in body composition in acromegaly
- (2008) Laurence Katznelson Pituitary
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search